BioSpace News Archive

Nkarta, Inc. announced the initiation of Ntrust-1, a multi-center clinical trial of NKX019 in lupus nephritis, with the first patient in screening.

CureLab Oncology, a clinical-stage biotech company, has filed a patent application with worldwide potential for a revolutionary wound-healing therapy based on its p62/SQSTM1 DNA plasmid.

X4 Pharmaceuticals announced positive new clinical data from its ongoing Phase 2 clinical trial evaluating the safety and efficacy of mavorixafor, an oral CXCR4 antagonist, in the treatment of people with chronic neutropenia.

Zomedica Corp. announced the commercial launch of its second equine focused assay - Cortisol for equine serum - for the point-of-care TRUFORMA® diagnostic platform.

Quest Diagnostics, a leader in diagnostic information services, released its 2023 Corporate Responsibility Report.

OraSure Technologies, Inc., a leader in point-of-care and home diagnostic tests and sample management solutions announced its support of HIV testing initiatives taking place across the nation in recognition of National HIV Testing Day, held each year on June 27th.

Clearside Biomedical, Inc., a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space, announced plans to host a virtual key opinion leader event on Wednesday, July 24, 2024 from 8:00 - 9:15 am ET.

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces the appointment of Ms Laurene Danon as Chief Financial Officer.

Bioxodes SA, a clinical stage biopharmaceutical company developing novel therapies for the prevention and treatment of thrombotic and inflammatory diseases, announces that it has enrolled the first eight of 32 patients in a Phase 2a clinical study of its lead asset BIOX-101.

ANEW MEDICAL, INC. announces a strategic partnership with Drs. Makoto Suzuki, Craig and Bradley Willcox, Richard Allsopp, and Michio Shimabukuro of Japan’s Okinawa Research Center for Longevity Science for the research and development of ANEW’s patented Klotho gene therapy in enhancing longevity and reducing age-related diseases.